Literature DB >> 17596175

Trends in melanoma epidemiology suggest three different types of melanoma.

D Lipsker1, F Engel, B Cribier, M Velten, G Hedelin.   

Abstract

BACKGROUND: It has been suggested that the incidence of thin melanomas but not of thick tumours is rising in fair-skinned populations, although the reason for this discrepancy is not understood.
OBJECTIVES: To describe temporal trends in melanoma epidemiology in a limited part of France in order to confirm this observation and to provide an explanation.
METHODS: This is a retrospective population- and academic centre-based study in which all melanomas diagnosed in the department of the Bas-Rhin, France between January 1980 and December 2004 were included.
RESULTS: The study included 2094 melanomas diagnosed in 2020 patients. There was a steady increase in incidence of thin (< 1 mm) melanomas, mainly located on the trunk, and to a lesser extent in the head and neck region, in both sexes, and of intermediate (1-2 mm) melanomas in men. The incidence of intermediate melanomas in women and of thick (> 2 mm) melanomas, as well as mortality related to melanoma, remained stable. There was a steady decline of mean and median Breslow thickness. The 12 months median delay to diagnosis of thick tumours was significantly shorter than the 24 months delay to diagnosis of thin tumours.
CONCLUSIONS: Temporal trends suggest the existence of three unrelated types of melanoma: type I, thick melanomas, with stable incidence; type II, thin melanoma with a steady and important increase in incidence, mainly located on the trunk; and type III, melanoma with a slower increase in incidence, mainly located on the head and neck region.

Entities:  

Mesh:

Year:  2007        PMID: 17596175     DOI: 10.1111/j.1365-2133.2007.08029.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  16 in total

1.  ["Indolent" pigmented skin tumor for more than 20 years].

Authors:  C A F Diernaes; J E F Diernaes; S Haase; A Blum
Journal:  Hautarzt       Date:  2017-10       Impact factor: 0.751

Review 2.  No one should die of melanoma: a vision or impossible mission?

Authors:  Iris Zalaudek; Elvira Moscarella; Caterina Longo; Aimilios Lallas; Giuseppe Argenziano; Rainer Hofmann-Wellenhof
Journal:  Melanoma Manag       Date:  2014-09-05

Review 3.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

4.  The prognostic importance of scalp location in primary head and neck melanoma.

Authors:  Junko Ozao-Choy; Daniel W Nelson; Jason Hiles; Stacey Stern; Jeong Lim Yoon; Myung Shin Sim; Mark B Faries
Journal:  J Surg Oncol       Date:  2017-05-22       Impact factor: 3.454

5.  Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.

Authors:  Juliette Delaunay; Ludovic Martin; Brigitte Bressac-de Paillerets; Gerard Duru; Olivier Ingster; Luc Thomas
Journal:  JAMA Dermatol       Date:  2017-11-01       Impact factor: 10.282

6.  Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells.

Authors:  Marina Pisano; Gabriella Pagnan; Maria Antonietta Dettori; Sara Cossu; Irene Caffa; Ilaria Sassu; Laura Emionite; Davide Fabbri; Michele Cilli; Fabio Pastorino; Giuseppe Palmieri; Giovanna Delogu; Mirco Ponzoni; Carla Rozzo
Journal:  Mol Cancer       Date:  2010-06-03       Impact factor: 27.401

7.  Increasing burden of melanoma in the United States.

Authors:  Eleni Linos; Susan M Swetter; Myles G Cockburn; Graham A Colditz; Christina A Clarke
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

8.  Male pattern baldness and risk of incident skin cancer in a cohort of men.

Authors:  Wen-Qing Li; Eunyoung Cho; Jiali Han; Martin A Weinstock; Abrar A Qureshi
Journal:  Int J Cancer       Date:  2016-09-08       Impact factor: 7.396

9.  Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study.

Authors:  John R Davies; Juliette Randerson-Moor; Kairen Kukalizch; Mark Harland; Rajiv Kumar; Srinivasan Madhusudan; Eduardo Nagore; Johan Hansson; Veronica Höiom; Paola Ghiorzo; Nelleke A Gruis; Peter A Kanetsky; Judith Wendt; Dace Pjanova; Susana Puig; Philippe Saiag; Dirk Schadendorf; Nadem Soufir; Ichiro Okamoto; Paul Affleck; Zaida García-Casado; Zighereda Ogbah; Aija Ozola; Paola Queirolo; Antje Sucker; Jennifer H Barrett; Remco van Doorn; D Timothy Bishop; Julia Newton-Bishop
Journal:  Pigment Cell Melanoma Res       Date:  2012-03-16       Impact factor: 4.693

10.  Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.

Authors:  Milena Casula; Antonio Muggiano; Antonio Cossu; Mario Budroni; Corrado Caracò; Paolo A Ascierto; Elena Pagani; Ignazio Stanganelli; Sergio Canzanella; Mariacristina Sini; Grazia Palomba; Giuseppe Palmieri
Journal:  BMC Cancer       Date:  2009-10-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.